ANI Pharmaceuticals, Inc. (ANIP)

ANI Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	40.57	-18.52	18.78	-47.9	-42.6	-22.55
Depreciation & Amortization	91.4	67.73	59.79	59.65	47.25	44.64
Stock-Based Compensation	35.22	29.34	20.65	14.6	10.49	12.94
Other Adjustments	-12.19	-3.35	-5.12	-6.26	-11.73	-7.13
Change in Receivables	-56.19	-21.09	3.36	-36.91	-5.55	-23.66
Changes in Inventories	-10.37	-21.29	-5.84	-23.63	3.22	-2.76
Changes in Accounts Payable	15.57	0.48	7.55	5.04	10.17	-2.29
Changes in Accrued Expenses	71.34	30	16.81	5.16	-0.48	12.97
Changes in Income Taxes Payable	-3.15	-1.42	11.99	-0.16	-7.57	4.88
Changes in Other Operating Activities	-2.26	2.13	-9.02	-0.8	0.13	-1.87
Operating Cash Flow	170.72	64.02	118.96	-31.2	3.32	15.27
Operating Cash Flow Growth	83.77%	-46.19%	-	-	-78.24%	-66.54%
Capital Expenditures	-14.99	-16.24	-8.87	-8.88	-2.56	-6.14
Sale of Property, Plant & Equipment	-	13.51	-	0.75	2.65	-
Purchases of Intangible Assets	-20.41	-0.72	-9.64	-7.58	-21.08	-62.19
Payments for Business Acquisitions	-8.2	-401.28	-	-0.03	-84.49	-
Investing Cash Flow	-43.6	-404.72	-18.51	-15.74	-105.48	-68.32
Short-Term Debt Issued	-	-	-	-	24	15
Short-Term Debt Repaid	-	-	-	-	-	-7.5
Net Short-Term Debt Issued (Repaid)	-	-	-	-	24	7.5
Long-Term Debt Issued	-	641.25	-	-	286.03	-
Long-Term Debt Repaid	-12.19	-296.03	-3	-3	-200.15	-8.03
Net Long-Term Debt Issued (Repaid)	-12.19	345.22	-3	-3	85.88	-8.03
Issuance of Common Stock	15.27	6.49	89.55	1.46	71.65	0.62
Repurchase of Common Stock	-11.92	-10.96	-4.99	-1.96	-0.89	-1.52
Net Common Stock Issued (Repurchased)	3.35	-4.47	84.56	-0.5	70.76	-0.91
Issuance of Preferred Stock	-	-	-	-	25	-
Net Preferred Stock Issued (Repurchased)	-	-	-	-	25	-
Preferred Share Dividends Paid	-1.56	-1.63	-1.63	-1.63	-0.19	-
Other Financing Activities	-3.88	-74.18	-12.5	-	-10.86	-
Financing Cash Flow	-10.22	264.95	67.44	-5.13	194.6	-1.44
Effect of Exchange Rate Changes on Cash and Cash Equivalents	0.73	-0.47	-	-	-	-
Net Cash Flow	117.63	-76.23	167.89	-52.07	92.43	-54.49
Free Cash Flow	155.73	47.78	110.09	-40.08	0.77	9.13
Free Cash Flow Growth	225.93%	-56.60%	-	-	-91.62%	-76.58%
FCF Margin	18.83%	7.78%	22.61%	-12.67%	0.35%	4.38%
Free Cash Flow Per Share	7.80	2.47	6.05	-2.46	-	0.76
Levered Free Cash Flow	124.69	388.09	88.2	-14.51	117.44	26.36
Unlevered Free Cash Flow	205.3	61.88	116.81	9.42	19.92	35.54

Updated Feb 27, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q